The scientific reference for hyperbaric oxygen therapy.
Mechanisms, FDA-approved indications, clinical protocols, longevity applications, and peer-reviewed evidence. Bilingual EN/EL. No marketing, no chatbot — only what the literature supports.
14
FDA-Approved Indications
UHMS recognized conditions
>20%
Telomere Lengthening
In healthy older adults (60 sessions)
258
Peer-Reviewed Citations
Supporting the evidence base
2.0–3.0 ATA
Treatment Pressure
Standard therapeutic range
Two paths, one evidence base
Hospitals and longevity operators come to HBOT from different angles — but the underlying science is the same. Pick the path that matches your starting question.
For hospitals & clinics
Clinical Integration
FDA-approved indications, evidence levels, departmental application mapping, protocol summaries, and strategic recommendations for hospital integration.
Explore clinical
For wellness & longevity operators
Wellness & Longevity
Telomere lengthening, senescent cell reduction, cognitive enhancement, athletic recovery — protocols, evidence, and operator reference architecture.
Explore wellness
Reference library
The same source material, organised for direct lookup. Linked from both paths above and from every detail page across the site.
Mechanisms of Action
Five physiological mechanisms — hyperoxygenation, angiogenesis, antimicrobial activity, gas reduction, anti-ageing pathways.
Indications
19 indications across two evidence tiers — 14 FDA-approved (UHMS-recognised) and 5 emerging — with evidence levels, protocols, and key references.
Evidence Base
Peer-reviewed RCTs, meta-analyses, and prospective studies — DOI links to source publications.
Bibliography
All cited sources with direct links. Used as the citation backbone across every claim on the site.